These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10521730)

  • 21. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
    Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
    Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragile X syndrome and fragile XE mental retardation.
    Sutherland GR; Mulley JC
    Prenat Diagn; 1996 Dec; 16(13):1199-211. PubMed ID: 9061751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who should be tested for fragile X carriership? A review of 1 center's pedigrees.
    Rajendra K; Bringman JJ; Ward J; Phillips OP
    Am J Obstet Gynecol; 2008 May; 198(5):e51-3. PubMed ID: 18358452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACOG committee opinion. No. 338: Screening for fragile X syndrome.
    American College of Obstetricians and Gynecologists Committee on Genetics
    Obstet Gynecol; 2006 Jun; 107(6):1483-5. PubMed ID: 16738187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.
    McConkie-Rosell A; Finucane B; Cronister A; Abrams L; Bennett RL; Pettersen BJ
    J Genet Couns; 2005 Aug; 14(4):249-70. PubMed ID: 16047089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.
    Tzeng CC; Tsai LP; Chang YK; Hung YJ; Chang YY; Su YP; Jiang JJ; Liang HM
    Clin Genet; 2017 Aug; 92(2):217-220. PubMed ID: 28139839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragile X syndrome prenatal diagnosis: parental attitudes and reproductive responses.
    Xunclà M; Badenas C; Domínguez M; Rodríguez-Revenga L; Madrigal I; Jiménez L; Soler A; Borrell A; Sánchez A; Milà M
    Reprod Biomed Online; 2010 Oct; 21(4):560-5. PubMed ID: 20801083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fragile X syndrome carrier screening in the prenatal genetic counseling setting.
    Cronister A; DiMaio M; Mahoney MJ; Donnenfeld AE; Hallam S
    Genet Med; 2005 Apr; 7(4):246-50. PubMed ID: 15834242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
    Ryynänen M; Heinonen S; Makkonen M; Kajanoja E; Mannermaa A; Pertti K
    Eur J Hum Genet; 1999; 7(2):212-6. PubMed ID: 10196705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragile X screening: attitudes of genetic health professionals.
    Acharya K; Ross LF
    Am J Med Genet A; 2009 Feb; 149A(4):626-32. PubMed ID: 19291766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of carrier screening and prenatal diagnosis for FMR1 gene in 819 cases].
    Li J; Du J; Yang Q; Xu J; Li M; Fu H; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1104-1107. PubMed ID: 32924111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.
    Berkenstadt M; Ries-Levavi L; Cuckle H; Peleg L; Barkai G
    Prenat Diagn; 2007 Nov; 27(11):991-4. PubMed ID: 17705235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening for fragile X syndrome. International experiences].
    Vuust J; Larsen LA; Grønskov K; Nørgaard-Pedersen B; Brøndum-Nielsen K
    Ugeskr Laeger; 2006 Oct; 168(43):3704-9. PubMed ID: 17069733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review of population screening for fragile X syndrome.
    Hill MK; Archibald AD; Cohen J; Metcalfe SA
    Genet Med; 2010 Jul; 12(7):396-410. PubMed ID: 20548240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular biology of fragile X syndrome: recent data and diagnostic applications].
    Mornet E; Simon-Bouy B
    Arch Pediatr; 1996 Aug; 3(8):814-21. PubMed ID: 8998538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conflicts regarding genetic counseling for fragile X syndrome screening: a survey of clinical geneticists and genetic counselors in Israel.
    Lieberman S; Zuckerman S; Levy-Lahad E; Altarescu G
    Am J Med Genet A; 2011 Sep; 155A(9):2154-60. PubMed ID: 21834046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragile X testing in obstetrics and gynaecology in Canada.
    Chitayat D; Wyatt PR; ;
    J Obstet Gynaecol Can; 2008 Sep; 30(9):837-841. PubMed ID: 18845054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.